Pharmacy Board Reassures Public on Paracetamol Use During Pregnancy

The Pharmacy and Poisons Board (PPB) has moved to reassure expectant mothers that paracetamol remains safe for use during pregnancy, as long as it is taken under the guidance of a qualified healthcare professional.

In a statement on Thursday, PPB CEO Ahmed Mohamed said paracetamol continues to be a recommended medicine for relieving pain and fever in pregnant women.

Paracetamol is one of the most commonly used drugs in Kenya and across the world. While some studies have suggested possible links between its use during pregnancy and conditions such as autism spectrum disorder (ASD) or attention deficit hyperactivity disorder (ADHD) in children, Mohamed noted that there is no conclusive scientific evidence confirming these claims.

“The PPB’s Pharmacovigilance Division has not received any reports linking paracetamol use in pregnancy to ASD or ADHD. The Division continues to monitor the safety of medicines used during pregnancy to protect the health of mothers and children,” he said.

Mohamed advised that paracetamol should only be taken when necessary, in the correct dose and duration, and strictly under prescription. He cautioned that pregnant women should not take any medication without professional guidance.

He further urged healthcare providers to counsel expectant mothers on the safe use of paracetamol and other medicines during pregnancy.

“The Board reaffirms its commitment to safeguarding public health through continuous monitoring of the safety of medicines, including those used during pregnancy, and will provide timely updates as necessary,” Mohamed said.

The PPB also encouraged healthcare workers and members of the public to report any suspected side effects from medicines, including paracetamol.